Ariane Laparra

943 citations
21 papers · 503 indexed · 1 hit paper · h-index 9
Topics
Cancer Immunotherapy and Biomarkers (12 papers)Lung Cancer Treatments and Mutations (7 papers)CAR-T cell therapy research (4 papers)
Journals
SHILAP Revista de lepidopterologíaAntimicrobial Agents and ChemotherapyAnnals of Oncology

In The Last Decade

Ariane Laparra

16 papers receiving 497 citations

Hit Papers

Evaluation of Readministration of Immune Checkpoint Inhib...2019202620212023201950100150200250

Peers

Ariane Laparra
Comparison fields: 5 of 73
  • Oncology 365
  • Pulmonary and Respiratory Medicine 146
  • Immunology 89
  • Molecular Biology 71
  • Epidemiology 59
Replace Gary W. Jean with:
Gary W. Jean United States
Eli P. Darnell United States
Tomoki Tamura Japan
Ioannis P. Trontzas Greece
Charlotte Mussini France
Daniel Leino United States
Takahiko Akiyama Japan
Dominik A. Barth Austria
Ardaman Shergill United States
Rohan Mandaliya United States
Ariane Laparra relative to Gary W. Jean United States Gary W. Jean's profile →
Citations per field
00.5×11.1×
Gary W. Jean · 1×
Citations per year

Countries citing papers authored by Ariane Laparra

Since Specialization
Citations

This map shows the geographic impact of Ariane Laparra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariane Laparra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariane Laparra more than expected).

Fields of papers citing papers by Ariane Laparra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariane Laparra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariane Laparra. The network helps show where Ariane Laparra may publish in the future.

Co-authorship network of co-authors of Ariane Laparra

This figure shows the co-authorship network connecting the top 25 collaborators of Ariane Laparra. A scholar is included among the top collaborators of Ariane Laparra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariane Laparra. Ariane Laparra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 1
5 4
6 2
7 36
8 0
9 6
10 11
11 0
12 13
13 58
14 6
15 0
16 5
17 26
18
Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancerbreakdown →
272
19 39
20 14

About Ariane Laparra

Ariane Laparra is a scholar working on Oncology, Biological Psychiatry and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 503 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Treatments and Mutations (7 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Oncology (365 citations), Pulmonary and Respiratory Medicine (146 citations) and Immunology (89 citations). Ariane Laparra has collaborated with scholars based in France, United States and Cyprus. Frequent co-authors include Olivier Lambotte, Jean‐Marie Michot, Stéphane Champiat, Aurélien Marabelle, Christophe Massard, Jérôme Le Pavec, Antoine Hollebecque, Aurore Vozy, Michael Collins and Anne Laure Voisin. Their work appears in journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026